SPONSOR
University of Sao Paulo
Total Trials
8
Recruiting
8
Phases
Phase 1, Phase 2, Phase 2
Conditions studied: Type 1 DiabetesLeukemia, Acute LymphoblasticLymphoma, Non-HodgkinPeriodontitisObesityAcute Coronary Syndromes (ACS)Troponin IPoint-of-Care TestingCardio Vascular DiseaseRheumatic Diseases
University of Sao Paulo is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Type 1 Diabetes, Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin, Periodontitis.
The trial portfolio spans Phase 1, Phase 2, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Sao Paulo
How many clinical trials has University of Sao Paulo sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by University of Sao Paulo, of which 8 are actively recruiting participants. These trials cover conditions including Type 1 Diabetes, Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Sao Paulo research focus on?
University of Sao Paulo clinical trials span Type 1 Diabetes, Leukemia, Acute Lymphoblastic, Lymphoma, Non-Hodgkin, Periodontitis, Obesity, and additional conditions. The research pipeline includes Phase 1, Phase 2, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Sao Paulo clinical trial?
To participate in a University of Sao Paulo trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Sao Paulo trials with current recruitment status updated daily.
Clinical Trials by University of Sao Paulo
NCT07150052
Recruiting
Efficacy and Safety of an Artificial Intelligence Tool for Carbohydrate Counting (Tiabete) in Children and Adults With Type 1 Diabetes Mellitus
Type 1 Diabetes
NCT06101381 Phase 1, Phase 2
Recruiting
CD19-directed CAR-T Cell Therapy for R/R Acute Leukemia and Lymphoma
Leukemia, Acute Lymphoblastic
NCT06073704
Recruiting
Effects of Adjunct Antimicrobial Photodynamic Therapy in Periodontal Treatment of Patients With Obesity
Periodontitis
NCT06861582
Recruiting
Effect of Point-of-care Analysis of Ultrasensitive Troponin I on Length of Hospital Stay in Patients With Cardiac Chest Pain (POC Troponina)
Acute Coronary Syndromes (ACS)
NCT07774845
Recruiting
Platelets and Plasma Lipids Relationship as a Biomarker and Potential Therapeutic Target of Thrombogenesis
Cardio Vascular Disease
NCT04890483
Recruiting
tDCS in Post-Acute COVID-19 Patients With SARDs
Rheumatic Diseases
NCT07317206 Phase 2
Recruiting
Ayahuasca, Esketamine and PTSD
Posttraumatic Stress Disorder (PTSD)
NCT07170007
Recruiting
Physiotherapeutic Protocol Compared to Usual Care in the Treatment of Primiparas After Perineal Trauma
Episiotomy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology